- Stressed and Distracted, Kids and Their Teachers Say Virtual Learning Isn’t Working
- Fauci Says U.S. Will Stay With Two Doses of Pfizer, Moderna Vaccines
- Health Highlights, March 2, 2021
- Many Blacks, Hispanics Believe They’ll Get Worse Care If Dementia Strikes
- For Some Young Drivers, Smartphone Use Is One of Many Bad Habits
- Strep Throat Doesn’t Worsen Tourette But May Affect ADHD: Study
- Sports Position Doesn’t Affect Risk of Concussion-Linked CTE Illness
- ‘Telestroke’ Care at Hospitals Is Boosting Patient Outcomes
- Face Masks Won’t Impede Your Breathing, Study Confirms
- Pot May Not Be the Best Rx for a Migraine
New Additive Aids Blood Platelet Storage
THURSDAY, Dec. 10An additive that allows for more efficient storage of blood platelets up to five days has been approved by the U.S. Food and Drug Administration.
Platelets — the component that helps blood clot — are commonly used to prevent or treat bleeding, are given to people having chemotherapy to treat cancer, and are administered to people who don’t produce their own platelets, the agency said in a news release.
Currently, platelets are stored in a solution made from a component of blood plasma. The newly approved additive, InterSol, will free up some of the donor plasma for other purposes, the FDA said.
InterSol is derived from salt. It’s manufactured by Illinois-based Fenwal Inc.
More information
To learn more about blood platelets, visit the University of Oklahoma Health Sciences Center.
Source: HealthDay
